Although not directly associated with Aβ deposition, ZNF179 plays a protective role in AD by regulating the CCAAT/enhancer binding protein delta (CEBPD), which is a transcription factor found in activated astrocytes that surround β-amyloid plaques. Here, CEBPD is linked to Alzheimer disease.